Pharmacogenomics Using Artificial Intelligence: Optimizing Drug Response through Personalized Genomic Analysis

Bridging the critical gap between complex genomic data and actual clinical practice, this essential volume delivers the cutting-edge AI methodologies, expert bioinformatics insights, and practical case studies needed to unlock truly personalized medicine.

The intersection of artificial intelligence and pharmacogenomics represents a transformative change in the life sciences industry. Pharmacogenomics, the study of how genetic variations influence an individual’s response to drugs, has long held the promise of enabling personalized treatments that are tailored to the genetic profile of individual patients, improving therapeutic outcomes and minimizing adverse drug reactions. However, the complexity of genomic data, massive scale of information, and challenge of interpreting the intricate relationships between genetic variations and drug responses have impeded the widespread implementation of personalized treatments in clinical practice. This volume explores how AI technologies are transforming personalized medicine by optimizing drug responses based on individual genetic profiles. The book will provide a comprehensive look at the role of AI in advancing pharmacogenomic research and its application in clinical practice, enabling healthcare professionals to predict the most effective and safest drugs for individual patients.

The book will be structured around the application of cutting-edge AI techniques in analyzing genomic data. Each chapter will highlight different aspects of AI-driven pharmacogenomics, from drug development and genetic variant identification to clinical implementation and ethical considerations. Experts from diverse fields, including bioinformatics, pharmacology, and data science, will contribute insights into how AI can be harnessed to analyze large genomic datasets, predict patient-specific drug responses, and overcome existing challenges in precision medicine. This volume will not only provide theoretical knowledge but also offer practical examples, case studies, and methodologies that researchers, clinicians, and healthcare professionals can utilize to enhance pharmacogenomic research and personalize patient care.

Umesh Kumar Lilhore, PhD is a Professor at Galgotias University, Greater Noida, India with more than 20 years of experience. He has authored ten books and more than 100 research articles in international journals and filed 50 patents across India and the United Kingdom. His research focuses on network security, computer networking, and the Internet of Things.

Kaamran Raahemifar, PhD is a Professor in the College of Information Sciences and Technology at Penn State University. He has authored and co-authored numerous highly cited publications and books in reputed international journals and conferences. His research focuses on AI-driven healthcare systems, machine learning, optimization, medical image processing, and intelligent smart systems.

Sarita Simaiya, PhD is a Professor at Galgotias University, Greater Noida, India with more than 18 years of experience. She has co-authored several peer-reviewed publications in reputed international journals and conferences, with a focus on integrating emerging AI technologies into healthcare and biomedical research. Her research interests include AI-driven healthcare systems, deep learning models, and intelligent data analytics for biomedical applications.

R. Sunder, PhD is an academician and researcher with expertise in artificial intelligence, machine learning, data analytics, and intelligent healthcare systems. His research interests include AI-driven biomedical applications, computational intelligence, and advanced data processing techniques for healthcare and pharmaceutical domains. He has contributed to interdisciplinary research projects and scholarly publications focused on emerging technologies and digital healthcare innovation.

R. Lotus, PhD is a researcher and academician specializing in artificial intelligence, computational biology, and healthcare technologies. She has contributed to multidisciplinary research initiatives and scholarly publications focused on advancing digital healthcare, precision medicine, and emerging computational technologies. She is actively engaged in promoting innovative AI solutions for healthcare and biomedical research.